McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in an April 17, 2017 edition of Bloomberg BNA’s Life Sciences Law & Industry Report in an article entitled, “Patent Community Wants Congress to Amend, Clarify Patent Eligibility.” Congress needs to amend the law on patent eligibility to counter recent Supreme Court decisions that have made it harder for life sciences companies to protect their intellectual property, attorneys told a conference. View the article